Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Shaofei Chang"'
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Background This study aims to elucidate the significance of the preoperative fibrinogen to pre-albumin ratio (FPR) in predicting the prognosis of pancreatic ductal adenocarcinoma (PDAC), a correlation not extensively explored previously. Met
Externí odkaz:
https://doaj.org/article/b28887a78bcc4e7a88a5e2ad0610dd34
Autor:
Yuexiang Liang, Guannan Sheng, Yu Guo, Yiping Zou, Hanhan Guo, Zhifei Li, Shaofei Chang, Quan Man, Song Gao, Jihui Hao
Publikováno v:
Cancer Biology & Medicine, Vol 21, Iss 5, Pp 416-432 (2024)
Objective: Tumor cell malignancy is indicated by histopathological differentiation and cell proliferation. Ki-67, an indicator of cellular proliferation, has been used for tumor grading and classification in breast cancer and neuroendocrine tumors. H
Externí odkaz:
https://doaj.org/article/cc3b41a61730440d859901ac92a3ddfd
Publikováno v:
Cancer Reports, Vol 6, Iss 12, Pp n/a-n/a (2023)
Abstract Background Carbohydrate antigen (CA) 19‐9 and histological grade can serve as indicators of the biological characteristics of pancreatic ductal adenocarcinoma (PDAC). Aims The aim of this study was to investigate the combined impact of pre
Externí odkaz:
https://doaj.org/article/190231213ca145a490d504df939c9f55
Autor:
Haorui Li, Yu Guo, Xugang Sun, Yang Lu, Shaofei Chang, Xiuchao Wang, Song Gao, Chuntao Gao, Tiansuo Zhao
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundA survival benefit has been seen for both adjuvant nab-paclitaxel plus gemcitabine (AG) and S-1 chemotherapy compared to gemcitabine (GEM) for resectable pancreatic cancer in the APACT (2019) and JASPAC01 trials (2016), respectively. Howeve
Externí odkaz:
https://doaj.org/article/3fc69ace759c423a9d5ec37c4bc6f727
Autor:
Yuexiang Liang, Jingli Cui, Fanghui Ding, Yiping Zou, Hanhan Guo, Quan Man, Shaofei Chang, Song Gao, Jihui Hao
Publikováno v:
iScience, Vol 26, Iss 9, Pp 107589- (2023)
Summary: The current TNM staging system for pancreatic ductal adenocarcinoma (PDAC) has revised the definitions of T and N categories as well as stage groups. However, studies validating these modifications have yielded inconsistent results. The exis
Externí odkaz:
https://doaj.org/article/3aa622c364d34fdfab3afb645ebefb1b
Publikováno v:
Journal of Surgical Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e44f8ae6537f48724fb9fe2b4616c691
https://doi.org/10.1002/jso.27362
https://doi.org/10.1002/jso.27362
Publikováno v:
Japanese Journal of Clinical Oncology; Nov2023, Vol. 53 Issue 11, p1058-1067, 10p
Autor:
Shaofei Chang, Haizheng Liu
Publikováno v:
BIOCELL. 46:453-462
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b7d8d72edcecb98ec915b007fdff0c
https://doi.org/10.32604/biocell.2021.015340
https://doi.org/10.32604/biocell.2021.015340
Preoperative serum CA19-9 and histology grade could show the biological characteristics of pancreatic ductal adenocarcinoma (PDAC). This study aims to explore the combined effect of preoperative CA19-9 and histology grade on the prognosis of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c0de1d9b6baa7b1d6872b91660a4b63
https://doi.org/10.21203/rs.3.rs-2653528/v1
https://doi.org/10.21203/rs.3.rs-2653528/v1
